China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com

Investment analysts at StockNews.com began coverage on shares of China Pharma (NYSE:CPHI – Get Rating) in a research report issued on Monday. The firm set a “hold” rating on the stock.

China Pharma Trading Up 13.4 %

Shares of NYSE:CPHI opened at $0.38 on Monday. The stock’s 50 day moving average price is $0.35. China Pharma has a twelve month low of $0.27 and a twelve month high of $4.15.

Get China Pharma alerts:

About China Pharma

(Get Rating)

China Pharma Holdings, Inc engages in the development, manufacture, and marketing of pharmaceutical products. The firm’s product portfolio includes Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases, Comprehensive Healthcare, and Protective Products.

Read More

• Get a free copy of the StockNews.com research report on China Pharma (CPHI)
• MarketBeat Week in Review – 5/29 – 6/2
• Trading Channel Breakout in Lululemon Brought by Earnings
• What Should Investors Make of These 3 Dividend Cuts?
• Constellation Brands Taps into Growth: Analysts Bullish on Stock
• CrowdStrike: Another Tech Stock to Buy on the Dip 

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.